Both in Pharmaceuticals
Adicet Bio vs NextCure
Over the past year ACET returned −72.9% and NXTC returned −50.7%; their daily moves had a correlation of 0.13.
ACET −72.9% NXTC −50.7%Growth of $1, one year, split-adjusted
| Metric | ACET | NXTC |
|---|---|---|
| Price | $3.17 | $5.91 |
| Market cap | $29.7M | $27.1M |
| Today | −0.94% | +3.78% |
| 1 month | −51.0% | +17.0% |
| 6 months | −62.7% | −36.6% |
| Year to date | −62.4% | −58.4% |
| 1 year | −73.6% | −53.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.4M | $20.1M |
| Dividend yield | — | — |
| Volatility (60d) | 96.9% | 111.0% |
| Short % of float | 6.3% | 8.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).